Clinical Trials

Showing trials with last updates posted in 2024.

NCT03601507 | TERMINATED | PHASE2
9 participants

Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2024-04-17
Start Date:
2019-03-11
Completion:
2022-05-24
Conditions
  • CDKN2A-p16 Positive
  • HPV Positive Oropharyngeal Squamous Cell Carcinoma
  • Stage I Oropharyngeal Squamous Cell Carcinoma AJCC V7
  • Stage II Oropharyngeal Squamous Cell Carcinoma AJCC V7
  • Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7
  • Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7
Interventions
  • DRUG
  • OTHER
  • PROCEDURE
Previous
Sorted by latest updates
Next
Showing 40 trials per page